Abstract 9 TableĀ 1
EndpointsNumber of Patients (N=51)
Patients with Treated Infection w/in 1-Month Prior to Rejection14/252 (5.6%)
Patients with Treated Infection w/in 1-Month Prior to de novo DSA4/252 (1.6%)